BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36944962)

  • 1. Clinical features and Surgical Outcome of Clear Cell Papillary Renal Cell Tumor: result from a prospective cohort.
    Kim SH; Han JH; Jeong SH; Yuk HD; Ku JH; Kwak C; Kim HH; Moon KC; Jeong CW
    BMC Urol; 2023 Mar; 23(1):41. PubMed ID: 36944962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell papillary renal cell carcinoma: Characteristics and survival outcomes from a large single institutional series.
    Steward JE; Kern SQ; Cheng L; Boris RS; Tong Y; Bahler CD; Masterson TA; Cary KC; Kaimakliotis H; Gardner T; Sundaram CP
    Urol Oncol; 2021 Jun; 39(6):370.e21-370.e25. PubMed ID: 33771410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.
    Geller JI; Cost NG; Chi YY; Tornwall B; Cajaiba M; Perlman EJ; Kim Y; Mullen EA; Glick RD; Khanna G; Daw NC; Ehrlich P; Fernandez CV; Dome JS;
    Cancer; 2020 Dec; 126(23):5156-5164. PubMed ID: 32926409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study.
    Kondo T; Sassa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
    Pathology; 2021 Oct; 53(6):720-727. PubMed ID: 33947521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Discordant Histology After Nephrectomy: Descriptive Analysis and Outcomes.
    Harlow BL; Klaassen Z; Holzman S; Reinstatler L; Franken AA; Kavuri SK; Terris MK; Master VA; Moses KA
    Clin Genitourin Cancer; 2016 Apr; 14(2):e171-5. PubMed ID: 26613833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
    Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
    Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial Comparison of Patients Undergoing Minimally Invasive Partial Nephrectomy for Renal Masses at a Large Volume Tertiary Center.
    Sands KG; Bhatt R; Vetter J; Paradis A; Chow AK; Bhayani S; Figenshau RS; Venkatesh R
    J Endourol; 2021 Sep; 35(9):1365-1371. PubMed ID: 33730861
    [No Abstract]   [Full Text] [Related]  

  • 9. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.
    Janssen MWW; Linxweiler J; Philipps I; Bütow Z; Siemer S; Stöckle M; Ohlmann CH
    World J Surg Oncol; 2018 Feb; 16(1):35. PubMed ID: 29463251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of "Recurrence".
    Bertolo R; Nicolas M; Garisto J; Magi-Galluzzi C; McKenney JK; Kaouk J
    Clin Genitourin Cancer; 2019 Jun; 17(3):209-215.e1. PubMed ID: 31000486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy.
    Chen L; Ma X; Li H; Gu L; Li X; Gao Y; Xie Y; Zhang X
    PLoS One; 2017; 12(3):e0173953. PubMed ID: 28288191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.
    Oh JJ; Byun SS; Lee SE; Hong SK; Lee ES; Kim HH; Kwak C; Ku JH; Jeong CW; Kim YJ; Kang SH; Hong SH
    Int J Urol; 2014 Apr; 21(4):352-7. PubMed ID: 24118633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Confederation of Urology (CAU) experience in minimally invasive partial nephrectomy.
    Secin FP; Castillo OA; Rozanec JJ; Featherston M; Holst P; Milfont JC; García Marchiñena P; Jurado Navarro A; Autrán A; Rovegno AR; Faba OR; Palou J; Teixeira Dubeux V; Nuñez Bragayrac L; Sotelo R; Zequi S; Guimarães GC; Álvarez-Maestro M; Martínez-Piñeiro L; Villoldo G; Villaronga A; Abreu Clavijo D; Decia R; Frota R; Vidal-Mora I; Finkelstein D; Monzó Gardiner JI; Schatloff O; Hernández-Porrás A; Santaella-Torres F; Quesada ET; Sánchez-Salas R; Dávila H; Mavric HV
    World J Urol; 2017 Jan; 35(1):57-65. PubMed ID: 27137994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: A Multicenter Analysis.
    Yim K; Aron M; Rha KH; Simone G; Minervini A; Challacombe B; Schips L; Berardinelli F; Quarto G; Mehrazin R; Patel D; Patel S; Bindayi A; Ashrafi AN; Desai M; Alqahtani A; Gallucci M; Sulek J; Mari A; De Luyk N; Anele U; Autorino R; Porpiglia F; Sundaram CP; Gill IS; Perdona S; Derweesh IH
    Eur Urol Focus; 2021 Sep; 7(5):1107-1114. PubMed ID: 33249089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
    Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Operative safety and oncologic outcome of laparoscopic radical nephrectomy for renal cell carcinoma >7 cm: a multicenter study of 222 patients.
    Luciani LG; Porpiglia F; Cai T; D'Elia C; Vattovani V; Giusti G; Tiscione D; Chiodini S; Peschechera R; Fiori C; Spina R; Parma P; Celia A; Malossini G
    Urology; 2013 Jun; 81(6):1239-44. PubMed ID: 23608667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical management for local retroperitoneal recurrence of 33 renal cell carcinoma patients underwent radical nephrectomy].
    Huang JW; Cai W; Kong W; Zhang J; Chen YH; Huang YR
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):703-707. PubMed ID: 31550862
    [No Abstract]   [Full Text] [Related]  

  • 20. Salvage surgery after energy ablation for renal masses.
    Karam JA; Wood CG; Compton ZR; Rao P; Vikram R; Ahrar K; Matin SF
    BJU Int; 2015 Jan; 115(1):74-80. PubMed ID: 24656119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.